MAM
GRTS

Martingale Asset Management’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Martingale Asset Management’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-16,000
Closed -$206K – 883
2021
Q4 		$206K Buy
+16,000
New +$177K ﹤0.01% 792
2020
Q4 		– Sell
-14,500
Closed -$39K – 1066
2020
Q3 		$39K Sell
14,500
-129,015
-90% -$479K ﹤0.01% 1014
2020
Q2 		$954K Buy
+143,515
New +$966K 0.01% 739

Other funds holding GRTS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Martingale Asset Management's GRTS Position: Q1 2022 in Review

Martingale Asset Management sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q1 2022, closing a stake of 16,000 shares — an estimated $206K sold.

Martingale Asset Management first reported a position in GRTS in Q2 2020 and held it in 3 quarters. The position peaked at $954K in Q2 2020. 117 funds tracked by Wall St. Rank hold GRTS as of Q1 2022.

  • Martingale Asset Management reported no remaining Gritstone bio, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Martingale Asset Management sold 16,000 Gritstone bio, Inc. Common Stock shares in Q1 2022, an estimated $206K.
  • Martingale Asset Management first reported a position in Gritstone bio, Inc. Common Stock in Q2 2020 and held it in 3 quarters.
  • Martingale Asset Management's Gritstone bio, Inc. Common Stock position peaked at $954K in Q2 2020.
  • 117 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q1 2022.

Based on Martingale Asset Management's 13F filing for Q1 2022, filed 12 May 2022.